Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Change

23 Feb 2024 10:30

RNS Number : 1814E
Xaar PLC
23 February 2024
 

23 February 2024

Xaar plc

Board Change

Xaar plc, ("the Company" or "Xaar"), a leading inkjet printing technology group, announces today the appointment of Stuart Widdowson to the Board as a Non-Executive Director effective from 27 February 2024.

Mr Widdowson is appointed as a representative of Odyssean Capital LLP ("Odyssean"), pursuant to a relationship agreement between the Company and Odyssean. The key terms are summarised in the notes below.

Mr Widdowson is the Managing Partner of Odyssean Capital, which he founded in 2017. From 2009 until 2017, he was lead fund manager of Strategic Equity Capital plc, which experienced a turnaround in its performance and rating during his tenure. He began his career as a strategy consultant undertaking commercial due diligence and strategy projects for private equity and corporate clients, before working for HgCapital, a leading private equity investor.

As at the last practicable date the total shareholding of funds managed by Odyssean Capital was 13,175,000 ordinary shares in the Company ("Ordinary Shares") representing approximately 16.6 per cent. of the Company's share capital. Additionally, Mr Widdowson beneficially owns 25,000 Ordinary Shares and the joint venture partner of Odyssean Capital, Harwood Capital, owns 1,050,000 Ordinary Shares.

Notes:

A summary of the key terms of the Relationship Agreement is as follows:

· Xaar has granted Odyssean the right to appoint Mr Widdowson to be a Director of the Company for appointment to the Board (the "Nominated Director") for so long as Odyssean has the right to exercise at least 10% or more of the Company's ordinary shares or voting rights attaching to the ordinary shares;

· Odyssean undertakes to, inter alia: (1) conduct all transactions and relationships with any member of Xaar's group on an arm's length basis; (2) not take any action which would have the effect of preventing Xaar or any member of Xaar's group from carrying on business independently of Odyssean or its associates; (3) not influence the day-to-day running of the Company (save through Mr Widdowson's role as the Nominated Director) and (4) not vote to prevent Xaar being managed in accordance with the principles of good governance set out in the UK Corporate Governance Code; and

· the Relationship Agreement will terminate (1) on the date upon which Odyssean ceases to hold at least 10% of the ordinary shares of the Company or the voting rights attaching to the ordinary shares of the Company; (2) on six months' notice written notice by either party at any time or immediately upon written notice in the event of a material breach of the Relationship Agreement; or (3) in the event that the Company's ordinary shares cease to be listed on the Official List or another recognised UK stock exchange.

Pursuant to Listing Rule 9.6.13, it is confirmed that Mr Widdowson was a director and shareholder of Durendal Limited, a fund management business, which was wound up in 2015. His shareholding was acquired by the majority shareholder and the cash was distributed to all shareholders before the company was voluntarily liquidated.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Stuart Widdowson to the Board.

Enquiries:

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATTMPTMTTTBFI
Date   Source Headline
27th Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 20077:00 amRNSHolding(s) in Company
20th Mar 20071:38 pmRNSHolding(s) in Company
19th Mar 20074:02 pmRNSHolding(s) in Company
15th Mar 200711:29 amRNSDividend Record Date Amendmnt
15th Mar 20077:01 amRNSFinal Results
6th Mar 20076:30 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSNotice of Final Results
14th Feb 20077:01 amRNSOffer Talks Terminated
12th Feb 20076:22 pmRNSHolding(s) in Company
9th Feb 200712:02 pmRNSEPT Disclosure
9th Feb 200710:14 amRNSRule 8.3- Xaar PLC
8th Feb 200711:53 amRNSRule 8.3- Xaar PLC
7th Feb 200711:20 amRNSEPT Disclosure
5th Feb 200710:56 amRNSEPT Disclosure
2nd Feb 200712:12 pmRNSEPT Disclosure
2nd Feb 200710:35 amRNSRule 8.3- Xaar PLC
31st Jan 200712:38 pmRNSRule 8.3- Xaar PLC
31st Jan 200712:02 pmRNSRule 8.3- Xaar PLC
30th Jan 20071:07 pmPRNRule 8.3 - XAAR PLC
30th Jan 200710:48 amRNSRule 8.3- Xaar PLC
29th Jan 20079:46 amRNSRule 8.3- Xaar PLC
25th Jan 200710:32 amRNSEPT Disclosure
25th Jan 200710:21 amRNSRule 8.3- Xaar PLC
24th Jan 200710:06 amRNSRule 8.3- Xaar PLC
23rd Jan 20079:19 amRNSRule 8.3- Xaar PLC
22nd Jan 200711:32 amRNSRule 8.3- Xaar PLC
19th Jan 20079:45 amRNSRule 8.3- Xaar
17th Jan 200711:54 amRNSEPT Disclosure
16th Jan 200711:48 amRNSEPT Disclosure
16th Jan 20079:52 amRNSRule 8.3- Xaar PLC
15th Jan 200711:01 amRNSRule 8.3- Xaar PLC
12th Jan 200710:30 amRNSEPT Disclosure
29th Dec 20069:20 amRNSAdditional Listing
28th Dec 200611:46 amRNSEPT Disclosure
28th Dec 20068:50 amRNSAdditional Listing
27th Dec 20069:03 amRNSAdditional Listing
22nd Dec 20068:32 amRNSAdditional Listing
21st Dec 200612:28 pmRNSEPT Disclosure
21st Dec 200610:30 amRNSAdditional Listing
21st Dec 200610:29 amRNSAdditional Listing
20th Dec 20064:22 pmRNSHolding(s) in Company
19th Dec 200612:21 pmRNSTotal Voting Rights
19th Dec 200612:02 pmRNSEPT Disclosure
18th Dec 20061:34 pmRNSEPT Disclosure
18th Dec 20061:07 pmRNSRule 8.3- Xaar PLC
15th Dec 200612:45 pmRNSEPT Disclosure
12th Dec 20061:02 pmRNSEPT Disclosure
11th Dec 200611:52 amPRNRule 8.3
8th Dec 200612:29 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.